![]()
|
|
||||||||
(Received for publication, April 30, 1997)
From the Exosite I of the blood clotting proteinase, thrombin,
mediates interactions of the enzyme with certain inhibitors,
physiological substrates and regulatory proteins. Specific binding of a
fluorescein-labeled derivative of the COOH-terminal dodecapeptide of
hirudin ([5F] Hir54-65) to exosite I was used to probe
changes in the function of the regulatory site accompanying
inactivation of thrombin by its physiological serpin inhibitor,
antithrombin. Fluorescence-monitored equilibrium binding studies
showed that [5F]Hir54-65 and
Hir54-65 bound to human
Volume 272, Number 32,
Issue of August 8, 1997
pp. 19837-19845
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
,
Department of Pathology, Vanderbilt
University School of Medicine, Nashville, Tennessee 37232, the
¶ Center for Molecular Biology of Oral Diseases, University of
Illinois-Chicago, Chicago, Illinois 60612, and the
Department of
Veterinary Medical Chemistry, Swedish University of Agricultural
Sciences, S-75123 Uppsala, Sweden
-thrombin with
dissociation constants of 26 ± 2 nM and 38 ± 5 nM, respectively, while the affinity of the peptides for the stable thrombin-antithrombin complex was undetectable (
200-fold weaker). Kinetic studies showed that the loss of binding sites for [5F]Hir54-65 occurred with the same
time-course as the loss of thrombin catalytic activity. Binding of
[5F] Hir54-65 and Hir54-65 to thrombin
was correlated quantitatively with partial inhibition of the rate of
the thrombin-antithrombin reaction, maximally decreasing the
bimolecular rate constants 1.7- and 2.1-fold, respectively. These
results support a mechanism in which thrombin and the
thrombin-Hir54-65 complex can associate with antithrombin
and undergo formation of the covalent thrombin-antithrombin complex at
modestly different rates, with inactivation of exosite I leading to
dissociation of the peptide occurring subsequent to the rate-limiting
inactivation of thrombin. This mechanism may function physiologically
in localizing the activity of thrombin by allowing inactivation of
thrombin that is bound in exosite I-mediated complexes with regulatory proteins, such as thrombomodulin and fibrin, without prior dissociation of these complexes. Concomitant with inactivation of thrombin, the
thrombin-antithrombin complex may be irreversibly released due to
exosite I inactivation.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex PNAS, March 25, 2008; 105(12): 4661 - 4666. |
||||
![]() |
B. L. Henry, B. H. Monien, P. E. Bock, and U. R. Desai A Novel Allosteric Pathway of Thrombin Inhibition: EXOSITE II MEDIATED POTENT INHIBITION OF THROMBIN BY CHEMO-ENZYMATIC, SULFATED DEHYDROPOLYMERS OF 4-HYDROXYCINNAMIC ACIDS J. Biol. Chem., November 2, 2007; 282(44): 31891 - 31899. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Kroh, G. Tans, G. A. F. Nicolaes, J. Rosing, and P. E. Bock Expression of Allosteric Linkage between the Sodium Ion Binding Site and Exosite I of Thrombin during Prothrombin Activation J. Biol. Chem., June 1, 2007; 282(22): 16095 - 16104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tan, P. J. Dlugosz, J. Peng, Z. Zhang, S. M. Lapolla, S. M. Plafker, D. W. Andrews, and J. Lin Auto-activation of the Apoptosis Protein Bax Increases Mitochondrial Membrane Permeability and Is Inhibited by Bcl-2 J. Biol. Chem., May 26, 2006; 281(21): 14764 - 14775. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Anderson, K. Kokame, and J. E. Sadler Zinc and Calcium Ions Cooperatively Modulate ADAMTS13 Activity J. Biol. Chem., January 13, 2006; 281(2): 850 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Panizzi, R. Friedrich, P. Fuentes-Prior, H. K. Kroh, J. Briggs, G. Tans, W. Bode, and P. E. Bock Novel Fluorescent Prothrombin Analogs as Probes of Staphylocoagulase-Prothrombin Interactions J. Biol. Chem., January 13, 2006; 281(2): 1169 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Verhamme, P. E. Bock, and C. M. Jackson The Preferred Pathway of Glycosaminoglycan-accelerated Inactivation of Thrombin by Heparin Cofactor II J. Biol. Chem., March 12, 2004; 279(11): 9785 - 9795. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pechik, J. Madrazo, M. W. Mosesson, I. Hernandez, G. L. Gilliland, and L. Medved Crystal structure of the complex between thrombin and the central "E" region of fibrin PNAS, March 2, 2004; 101(9): 2718 - 2723. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Anderson, A. Nesset, and P. E. Bock Effects of Activation Peptide Bond Cleavage and Fragment 2 Interactions on the Pathway of Exosite I Expression during Activation of Human Prethrombin 1 to Thrombin J. Biol. Chem., November 7, 2003; 278(45): 44482 - 44488. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Anderson and P. E. Bock Role of Prothrombin Fragment 1 in the Pathway of Regulatory Exosite I Formation during Conversion of Human Prothrombin to Thrombin J. Biol. Chem., November 7, 2003; 278(45): 44489 - 44495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Flanagan, J.-C. Chen, Y. Miao, Y. Shao, J. Lin, P. E. Bock, and A. E. Johnson Signal Recognition Particle Binds to Ribosome-bound Signal Sequences with Fluorescence-detected Subnanomolar Affinity That Does Not Diminish as the Nascent Chain Lengthens J. Biol. Chem., May 9, 2003; 278(20): 18628 - 18637. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Baglin, R. W. Carrell, F. C. Church, C. T. Esmon, and J. A. Huntington Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism PNAS, August 20, 2002; 99(17): 11079 - 11084. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Verhamme, S. T. Olson, D. M. Tollefsen, and P. E. Bock Binding of Exosite Ligands to Human Thrombin. RE-EVALUATION OF ALLOSTERIC LINKAGE BETWEEN THROMBIN EXOSITES I AND II J. Biol. Chem., February 22, 2002; 277(9): 6788 - 6798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-K. Hwang, J. M. Grossman, S. Visvanathan, R. U. Chukwuocha, V. L. Woods Jr., D. T. Le, B. H. Hahn, and P. P. Chen Identification of Anti-Thrombin Antibodies in the Antiphospholipid Syndrome That Interfere with the Inactivation of Thrombin by Antithrombin J. Immunol., December 15, 2001; 167(12): 7192 - 7198. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Q. Monteiro, P. E. Bock, M. L. Bianconi, and R. B. Zingali Characterization of bothrojaracin interaction with human prothrombin Protein Sci., September 1, 2001; 10(9): 1897 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Betz and S. Krishnaswamy Regions Remote from the Site of Cleavage Determine Macromolecular Substrate Recognition by the Prothrombinase Complex J. Biol. Chem., April 24, 1998; 273(17): 10709 - 10718. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Anderson, A. Nesset, K. R. Dharmawardana, and P. E. Bock Characterization of Proexosite I on Prothrombin J. Biol. Chem., May 26, 2000; 275(22): 16428 - 16434. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Boskovic and S. Krishnaswamy Exosite Binding Tethers the Macromolecular Substrate to the Prothrombinase Complex and Directs Cleavage at Two Spatially Distinct Sites J. Biol. Chem., December 1, 2000; 275(49): 38561 - 38570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz Conformational Changes in Thrombin When Complexed by Serpins J. Biol. Chem., November 21, 2001; 276(48): 44828 - 44834. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |